New Type Of Drug To Prevent Migraines Heads To Market
(By Richard Harris for NPR) The Food Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines
Read More
Right-to-try bill headed for vote puts bigger burden on FDA to protect patients, Gottlieb says
(By Ike Swetlitz and Erin Mershon for STAT) WHITE OAK, Md. — The House is set to take up a
Read MoreMore patients are taking home recordings of their doctor visits. But who else could listen?
(By Casey Ross for STAT) Doctors across the U.S. have begun doing what once seemed unthinkable in a litigious health
Read MoreCDC: End in sight for 32-state E. coli outbreak linked to romaine
(By Mackenzie Bean for Becker’s Hospital Review) The harvest season for romaine lettuce linked to a national E. coli outbreak ended April
Read MoreVermont Legislators Pass A Drug Importation Law. So What?
(By Shefali Luthra for Kaiser Health News) This week, Vermont passed a first-in-the-nation law that would facilitate the state’s importation of prescription
Read MoreArmy ‘Leans In’ To Protect A Shooter’s Brain From Blast Injury
(By Jon Hamilton for NPR) For the first time, the U.S. military is speaking publicly about what it’s doing to
Read MoreWill an aspirin a day keep you from having another stroke?
There are no easy answers when it comes to preventing deadly blood clots in people in the elevated risk category.
Read MoreFDA calls out 39 drug companies for allegedly blocking access to generics
(By Erin Mershon for STAT) Johnson & Johnson’s Actelion Pharmaceuticals, Celgene, and Gilead Life Sciences are all potentially blocking generic
Read MoreHow A Drugmaker Gamed The System To Keep Generic Competition Away
(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read MoreCMS is initiating a National Coverage Analysis for CAR-T therapies
In 2017, the Food and Drug Administration approved the first chimeric antigen receptor (CAR)-T cell therapies, now the Centers for
Read More